Kriangkum Jitra, Taylor Brian J, Reiman Tony, Belch Andrew R, Pilarski Linda M
Department of Oncology, University of Alberta and Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada.
Clin Lymphoma. 2005 Mar;5(4):217-9. doi: 10.3816/clm.2005.n.002.
Clonotypic B cells of Waldenstrom's macroglobulinemia (WM) are CD20+ immunoglobulin (Ig) M+ IgD+ cells that lack ongoing somatic hypermutation and class switch recombination (CSR). Only a small compartment of clonotypic B cells express activation-induced cytosine deaminase. Activation by CD40L/interleukin-4 does not stimulate WM class switching. However, we found that the mutation of switch regions essential for CSR were present in IgM monoclonal gammopathy of unknown significance (MGUS) but absent from WM B cells, suggesting the possibility that not all IgM MGUS have the potential to give rise to WM, and further strengthening the hypothesis that the target cell in transformation to WM is an unusual type of B cell.
华氏巨球蛋白血症(WM)的克隆型B细胞是CD20 +免疫球蛋白(Ig)M + IgD +细胞,缺乏持续的体细胞超突变和类别转换重组(CSR)。只有一小部分克隆型B细胞表达活化诱导的胞嘧啶脱氨酶。CD40L/白细胞介素-4介导的激活不会刺激WM的类别转换。然而,我们发现,CSR所必需的转换区突变存在于意义未明的IgM单克隆丙种球蛋白病(MGUS)中,但在WM B细胞中不存在,这表明并非所有IgM MGUS都有发展为WM的可能性,进一步支持了向WM转化的靶细胞是一种特殊类型B细胞的假说。